Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus Aim 2 Regulatory News (OSEC)

Share Price Information for Octopus Aim 2 (OSEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.717%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 43.40
OSEC Live PriceLast checked at -
Octopus AIM VCT 2 is an Investment Trust

To provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a diverse portfolio of predominantly AIM-traded companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

20 Oct 2008 08:54

RNS Number : 1900G
Octopus IHT AIM VCT PLC
20 October 2008
 



Octopus (formerly CloseIHT AIM VCT plc ("Company" or "Fund")

20 October 2008

Interim Management Statement 

For the period from 1 June 2008 to 15 October 2008

In accordance with Rule 4.3 of the UK Listing Authority's Disclosure and Transparency rules, Octopus IHT AIM VCT plc presents an Interim Management Statement for the period 1 June 2008 to 15 October 2008, being the latest weekly valuation prior to the date of this statement.

Change of Manager

Shareholders will be aware that in the period covered by this report there has been a change to the corporate identity of the Company. Following the move by Andrew Buchanan and Kate Tidbury from Close investments Limited to Octopus Investments Limited, your Board agreed to novate the Management Agreement to Octopus Investments. As a result it was necessary to change the name of your Company which was approved at a General Meeting at the beginning of September. Shareholders existing share certificates have not been replaced and remain valid.

Financial Highlights 

As at 15 October 2008 

As at 30

September 2008

As at 31 

May 2008

As at 30 

November 2007

Net assets ('000)

£16,884

£17,929

£21,613

£23,518

Net asset value per share ("NAV")

67.6p

71.8p

86.5p

94.2p

Cumulative dividends paid since launch

5.4p

4.4p

4.4p

3.4p

Total return (NAV plus dividends paid)

73.0p

76.2p

90.9p

97.6p

Share price 

73.0p

73.0p

88.0p

94.0p

Premium/(discount) to NAV 

(8.0)%

1.7%

1.7%

(0.2)%

Investment Performance and Activity

Investors have faced a difficult time in the period covered by this report with significant turmoil in the stock market caused by the hiatus in the banking sector. The consequence has been a further reduction in share prices, most particularly amongst smaller companies, such as those this Venture Capital Trust ("VCT") invests in.  The total return, as a result, has fallen by 19.7between 1 May and 15 October. For the sake of comparison the FTSE AIM All Share Index has fallen by 53.5% between 1 June and 15 October and the FTSE SmallCap index by 31.9% in the same period.

Despite this market background not being conducive to flotations and further issues of new shares, this VCT has managed to make three new qualifying investments, totalling £2.1m. As at 15 October the fund is 65% invested in qualifying investments. It has until 30 November 2008 to reach the minimum 70% level required by HMRC regulations. With the current pipeline of opportunities your manager is confident of achieving this level. Following the change of manager outlined above, the reduction in the Close Special Situations Fund was accelerated and the final shares were sold in the period under review.

The total value of the AIM quoted investment portfolio at 15 October was £9.5m. These figures exclude cash holdings and are at bid prices.  

Ten largest holdings by value as at 15 October 2008

Company

Carrying value £'000

Percentage 

onet assets

IS Pharma 

753

4.6%

Research Now 

663

3.9%

Animalcare Group 

654

3.8%

Advanced Computer Software

618

3.7%

Pressure Technologies

577

3.4%

Tasty

550

3.3%

Essentaily

527

3.1%

Mount Engineering plc

499

3.0%

Clerkenwell Ventures plc

468

2.8%

Neuropharm plc

442

2.6%

Dividends 

As stated in the interim report for the 6 months ended 31 May 2008, a dividend of 1.0p per 'A' and 'B' Ordinary share was declared and this was paid to shareholders on 10 October 2008.

Buybacks 

During the period the Fund bought back 15,250 'A' Ordinary shares at a price of 70p per share. These are currently held in Treasury.

Total voting rights and capital

At the date of this announcement, the capital of the Company consists of 7,299,461 'A' Ordinary shares and 17,680,650 'B' Ordinary shares with a nominal value of 0.01 pence each, with voting rights. Octopus IHT AIM VCT plc holds 15,250 'A' Ordinary Shares in Treasury.

Therefore, the total number of voting rights in the Company plc is 24,964,861.

The figure of 24,964,861 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Octopus IHT AIM VCT plc under the FSA's Disclosure and Transparency Rules.

Material events and transactions

The Board is not aware of any further material events or transactions between 15 October 2008 and the date of this report.

For further information please contact:

Andrew Buchanan/Kate Tidbury

Octopus Investments Limited 

Tel: 020 7710 2800

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKGMZGNGMGRZG
Date   Source Headline
1st Dec 20203:11 pmGNWTotal voting rights and Capital
30th Nov 20204:01 pmGNWClose of Offer to Further Apllications
25th Nov 202010:45 amGNWNet Asset Value(s)
19th Nov 20204:26 pmGNWTransaction in Own Shares and Total Voting Rights
17th Nov 20207:26 pmGNWNet Asset Value(s)
16th Nov 20205:45 pmGNWOffers for subscription - Over-Allotment Facility
13th Nov 20205:22 pmGNWNet Asset Value(s)
5th Nov 20203:30 pmGNWIssue of Equity and Total Voting rights
4th Nov 202011:43 amGNWNet Asset Value(s)
4th Nov 202010:58 amGNWNet Asset Value(s)
2nd Nov 202010:17 amGNWTotal voting rights and capital
29th Oct 20209:45 amGNWIssue of Equity and Total Voting Rights
27th Oct 202011:28 amGNWNet Asset Value(s)
22nd Oct 20207:15 pmGNWTransaction in Own Shares and Total Voting Rights
21st Oct 202011:46 amGNWNet Asset Value(s)
15th Oct 20204:02 pmGNWNet Asset Value(s)
14th Oct 202011:01 amGNWNet Asset Value(s)
9th Oct 20203:33 pmGNWNet Asset Value(s)
1st Oct 20204:55 pmGNWTotal voting rights and Capital
1st Oct 202010:36 amGNWNet Asset Value(s)
29th Sep 20203:00 pmGNWResult of General Meeting
24th Sep 20204:03 pmGNWTransaction in Own Shares and Total Voting Rights
23rd Sep 20202:16 pmGNWNet Asset Value(s)
22nd Sep 20207:33 pmGNWNet Asset Value(s)
11th Sep 20205:22 pmGNWNet Asset Value(s)
8th Sep 202011:19 amGNWNet Asset Value(s)
1st Sep 20201:02 pmGNWTotal Voting Rights and Capital
27th Aug 20205:56 pmGNWTransaction in Own Shares and Total Voting Rights
26th Aug 20203:49 pmGNWNet Asset Value(s)
20th Aug 20204:30 pmGNWPublication of Prospectus and Circular
19th Aug 20204:24 pmGNWPortfolio Update
18th Aug 20204:06 pmGNWNet Asset Value(s)
12th Aug 20205:49 pmGNWNet Asset Value(s)
6th Aug 20203:13 pmGNWNet Asset Value(s)
6th Aug 202010:42 amGNWNet Asset Value(s)
3rd Aug 20207:00 amGNWTotal Voting Rights and Capital
31st Jul 20204:09 pmGNWNet Asset Value(s)
23rd Jul 20204:58 pmGNWTransaction in Own Shares and Total Voting Rights
22nd Jul 202012:44 pmGNWNet Asset Value(s)
21st Jul 202010:14 amGNWNet Asset Value(s)
16th Jul 20201:46 pmGNWHalf-year report
16th Jul 202010:58 amGNWNet Asset Value(s)
16th Jul 20207:00 amGNWIntention to Fundraise
8th Jul 20202:45 pmGNWNet Asset Value(s)
2nd Jul 20203:25 pmGNWTotal Voting Rights and Capital
2nd Jul 20203:09 pmGNWNet Asset Value(s)
25th Jun 20206:54 pmGNWTransaction in Own Shares and Total Voting Rights
25th Jun 202010:36 amGNWIssue of Equity and Total Voting Rights
23rd Jun 20206:18 pmGNWNet Asset Value(s)
19th Jun 20204:54 pmGNWNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.